as on January 22, 2026 at 8:41 pm IST
Day's Low
Day's High
3.76%
Downside
0.54%
Upside
52 Week's Low
52 Week's High
71.77%
Downside
29.03%
Upside
Check ADC Therapeutics SA market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$436.0M
EPS (TTM)
-1.4033
Dividend Yield
0.00%
Quarterly Earnings Growth YOY
0.00%
PE Ratio (TTM)
0PEG Ratio
0EBITDA
-121.5M
Revenue (TTM)
75.2M
Profit Margin
-221.97%
Return On Equity TTM
-705.53%
Compare market cap, revenue, PE, and other key metrics of ADC Therapeutics SA with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % |
|---|---|---|---|---|---|
| BUY | $436.0M | -89.3% | NA | -221.97% | |
| BUY | $47.0B | 112.01% | 1269.75 | 1.36% | |
| BUY | $113.3B | 94.09% | 31.15 | 31.35% | |
| NA | $37.0B | NA | 619.04 | 1.38% | |
| BUY | $77.8B | 39.34% | 17.58 | 32.13% |
The ADC Therapeutics SA stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.
Investment Value
₹1,00,000
ADC Therapeutics SA investment value today
Current value as on today
₹2,24,736
Returns
₹1,24,736
(+124.74%)
Returns from ADC Therapeutics SA Stock
₹1,18,824 (+118.82%)
Dollar Returns*
₹5,913 (+5.91%)
Based on 12 analysts
83.33%
Buy
16.67%
Hold
0.00%
Sell
Based on 12 analysts, 83.33% of analysts recommend a 'BUY' rating for ADC Therapeutics SA. Average target price of $8
Get share price movements and forecasts by analysts on ADC Therapeutics SA.
What analysts predicted
53.5%UPSIDE
Target Price
$8
Current Price
$3.72
Analyzed by
12 Analysts
Target
$8.00
ADC Therapeutics SA target price $8, a slight upside of 53.5% compared to current price of $3.72. According to 12 analysts rating.
Search interest for ADC Therapeutics SA Stock has decreased by -84% in the last 30 days, reflecting a downward trend in search activity.
Time period: to
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Profit Spike
![]()
Netprofit is up for the last 2 quarters, -56.64M → -40.96M (in $), with an average increase of 38.3% per quarter
Best in 1 Year
![]()
In the last 1 year, ADCT has outperformed top 5 stocks with highest market-cap in its industry
Price Rise
![]()
In the last 1 year, ADCT stock has moved up by 110.0%
Against Peers
![]()
In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 28.2% return, outperforming this stock by 52.2%
Revenue Fall
![]()
Revenue is down for the last 3 quarters, 23.03M → 16.42M (in $), with an average decrease of 15.5% per quarter
| Organisation | ADC Therapeutics SA |
| Headquarters | BiopOle, Epalinges, Switzerland, 1066 |
| Industry | Health Technology |
| CEO | Dr. Ameet Mallik M.B.A., M.S. |
| E-voting on shares | Click here to vote |
Name | Title |
|---|---|
Ms. Nicole Riley | Head of Investor Relations & Corporate Communications |
Ms. Kristen Harrington-Smith | Chief Commercial Officer |
Dr. Ameet Mallik M.B.A., M.S. | CEO & Director |
Mr. Jose I. Carmona M.B.A. | Chief Financial Officer |
Dr. Mohamed Zaki M.D., Ph.D. | Chief Medical Officer |
Mr. Peter J. Graham Esq. | Secretary & Chief Legal Officer |
Ms. Kimberly Pope | Senior VP & Chief People Officer |
Ms. Lisa Michelle Kallebo | Corporate Controller & Chief Accounting Officer |
Dr. David S. Ege Ph.D. | Chief Technical Officer |
Dr. Patrick van Berkel Ph.D. | Chief Scientific Officer |
ADC Therapeutics SA share price today is $3.72 as on . ADC Therapeutics SA share today touched a day high of $3.74 and a low of $3.58.
ADC Therapeutics SA share touched a 52 week high of $4.8 on and a 52 week low of $1.05 on . ADC Therapeutics SA stock price today i.e. is trending at $3.72,which is 22.50% down from its 52 week high and 254.29% up from its 52 week low.
ADC Therapeutics SA market capitalisation is $0.00T as on .
Indian investors can start investing in ADC Therapeutics SA (ADCT) shares with as little as ₹91.567 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹915.67 in ADC Therapeutics SA stock (as per the Rupee-Dollar exchange rate as on ).
Based on ADC Therapeutics SA share’s latest price of $3.72 as on January 22, 2026 at 8:41 pm IST, you will get 2.6882 shares of ADC Therapeutics SA. Learn more about
fractional shares .
ADC Therapeutics SA stock has given -89.3% share price returns and 24.55% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?